Luo B

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Salivary Abeta(1-42) may be a quick-tested biomarker for clinical use in Alzheimer's disease: a meta-analysis - Fan_2022_J.Neurol__
Author(s) : Fan Z , Li Z , Zhao S , Chen Y , Su Y , Peng G , Luo B
Ref : Journal of Neurology , : , 2022
Abstract : Fan_2022_J.Neurol__
ESTHER : Fan_2022_J.Neurol__
PubMedSearch : Fan_2022_J.Neurol__
PubMedID: 36562850

Title : Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial - Xiao_2017_Age.Ageing__1
Author(s) : Xiao S , Wang T , Ma X , Qin Y , Li X , Zhao Z , Liu X , Wang X , Xie H , Jiang Q , Sun L , Luo B , Shang L , Chen W , Bai Y , Tang M , He M , Wu L , Ma Q , Hou D , He J
Ref : Age Ageing , :1 , 2017
Abstract : Xiao_2017_Age.Ageing__1
ESTHER : Xiao_2017_Age.Ageing__1
PubMedSearch : Xiao_2017_Age.Ageing__1
PubMedID: 28419192